get a key
steadybase-$ person John Geller
nameJohn Geller
roleCFO
company Trinity Biotech plc TRIB
linkedin none on file
contactnot published
filingsnone on file
quotes
As we mentioned on our last conference call, we expect that the MECO investment will support us in refinancing the perceptive debt in the near term by reducing our leverage.

Jun 30, 2022 / CFO / receipt, needs a key / John Geller, CFO | earnings call 2022-06-30 | transcript 25f646b9-9ced-4073-9aab-94e90295675d | chars 10125-10298 | segment 10

steadybase-$